Analysts expect revenue increase GlaxoSmithKline, quite high dividend

Tomorrow the English GlaxoSmithKline will publish its past quarter's figures. For this year GlaxoSmithKline 's revenue will be around 30,07 billion GBp. This is according to the average of the analysts' estimates. This is slightly more than 2016's revenue of 27,89 billion GBp.

Historical revenues and results GlaxoSmithKline plus estimates 2018

The analysts expect for 2018 a net profit of 5,41 billion GBp. The majority of the analysts expects for this year a profit per share of 110 GBp. Based on this the price/earnings-ratio is 11,64.

Huge dividend GlaxoSmithKline

Per share the analysts expect a dividend of 80 GBp per share. GlaxoSmithKline 's dividend yield thus equals 6,25 percent. The average dividend yield of the pharmaceutical companies equals a limited 1 percent.

Latest estimates around 1447 GBp

The most recent recommendations for the pharmaceutical company are from Jefferies & Co., Deutsche Bank and Kepler Capital Markets.

GlaxoSmithKline 's market capitalization is based on the number of outstanding shares around 6235,28 billion GBp.

At 10.02 the stock trades 1,56 percent lower at 1280,4 GBp.

Historical stock prices GlaxoSmithKline from 2007 till 2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.